Krill Oil for Pain in Elders
CompletedPhase 2NCT06580912
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic musculoskeletal pain contributes to mobility disability among older adults. Nutritional interventions, like omega-3 fatty acids, may help manage pain and improve physical function. Supplementation with krill oil may offer advantages to fish oil due to better absorption and additional nutrients. This pilot study aims to assess the feasibility of a clinical trial to determine the impact of krill oil supplementation on pain and function in older adults, informing future research.
Study details
- Official title
- Krill Oil for Pain and Physical Function in Older Adults
- Conditions
- Interventions
- Drug: Krill oil
- Dietary supplement: Mixed vegetable oil
- Sponsor
- University of Florida
- Collaborators
- National Institute on Aging (NIA)
- Start date
- 2025-01-17
- Primary completion
- 2025-12-17
- Sex
- All
- Age range
- from 60 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Able to provide informed consent * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged ≥60 years * Exhibiting chronic musculoskeletal pain of the hip, knees, or lower back (\>3 months) * Average pain ≥4 on a 0-10 numeric rating scale * Exhibiting moderate mobility limitations (Short Physical Performance Battery score 4-10) * Ability to take oral supplements and be willing to adhere to the supplementation regimen * Agreement to adhere to Lifestyle Considerations throughout study duration Exclusion Criteria: * Any known coagulation or bleeding disorders * Standing regimen of anticoagulants or full-dose aspirin * Regular use of opioids or high-dose NSAIDs * Taking medication known to affect muscle (e.g. steroids) * Taking selective serotonin reuptake inhibitors (SSRIs) * Omega-3 supplementation within the past 3 months * High consumption of fatty fish (\>2 servings/week) * Habitual supplementation with other complementary medicines/supplements that may affect the study results, including St. John's Wort * Known allergy to seafood * Clinically significant conditions: diabetes, severe cardiovascular disease, seizure disorders, uncontrolled hypertension (\>150/90mmhg at baseline), cancer or cancer that has been in remission \>5 years * History of atrial fibrillation or atrial flutter * Dementia * History of smoking, alcohol abuse, or illicit drug use * Ambulatory impairments which would limit the ability to perform physical function tests * Treatment with another investigational drug or other intervention within 3 months * Planning a surgical procedure during the study period * Planning to permanently leave the area during the study period
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06580912